Cart
sales@molnova.com
Diazolidinyl urea
CAS No. 78491-02-8
Diazolidinyl urea( Germall II )
Catalog No. M21198 CAS No. 78491-02-8
Diazolidinyl urea is a formaldehyde-releasing preservative used in cosmetics and personal-care products.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameDiazolidinyl urea
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiazolidinyl urea is a formaldehyde-releasing preservative used in cosmetics and personal-care products.
-
DescriptionDiazolidinyl urea is a formaldehyde-releasing preservative used in cosmetics and personal-care products.
-
In Vitro——
-
In Vivo——
-
SynonymsGermall II
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research AreaOthers
-
Indicationantimicrobial preservative
Chemical Information
-
CAS Number78491-02-8
-
Formula Weight278.22
-
Molecular FormulaC8H14N4O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:55 mg/mL (197.68 mM)
-
SMILESO=C1C(N(CO)C(=O)NCO)N(CO)C(=O)N1CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hectorne K J Fransway A F . Diazolidinyl urea: Incidence of sensitivity patterns of cross-reactivity and clinical relevance[J]. Contact Dermatitis 1994 30(1):16-19.
molnova catalog
related products
-
Oleclumab
Oleclumab (MEDI9447) is a human anti-CD73 monoclonal antibody with anticancer activity that inhibits the extracellular enzyme CD73 nucleic acid exonuclease activity, inhibits the adenosine pathway, and can be used for the study of metastatic desmoplasia-resistant prostate cancer.
-
Clozic
Clozic exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.
-
Ofatumumab
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation.
